Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance
David J. Zahavi(Georgetown University), Louis M. Weiner(Georgetown University), Theresa Guo(National Foundation for Cancer Research), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Elana J. Fertig(Bloomberg (United States)), Julia Wulfkuhle(University of California, San Francisco), Rosa I. Gallagher(George Mason University), Zoe X. Malchiodi(Georgetown University), Sandra A. Jablonski(Georgetown University), Rachael Maynard(Johns Hopkins University), Rossin Erbe(Johns Hopkins University), Yongwei Zhang(Albert Einstein College of Medicine), Alexander Lekan(Georgetown University)
Cited by 4
Related Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Monoclonal Antibodies in Cancer Therapy
|Antibodies|2020|799
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
|The Lancet Oncology|2020|541
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
|Science Translational Medicine|2015|502